Stock Watch: Gene Therapy’s Bittersweet Approvals
Two FDA Approvals Could Herald Two Different Financial Outcomes
Executive Summary
There are instances where the FDA approval of an unpartnered drug is the worst outcome for a biotech company. We may have just seen the first such gene therapy example.